Global Companion Diagnostic Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Immunohistochemistry
  • 1.2.3 Molecular Diagnosis
• 1.3 Market by Application
  • 1.3.1 Global Companion Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Oncology
  • 1.3.3 Cardiovascular
  • 1.3.4 Central Nervous System
  • 1.3.5 Virology
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Companion Diagnostic Market Perspective (2017-2028)
• 2.2 Companion Diagnostic Growth Trends by Region
  • 2.2.1 Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Companion Diagnostic Historic Market Size by Region (2017-2022)
  • 2.2.3 Companion Diagnostic Forecasted Market Size by Region (2023-2028)
• 2.3 Companion Diagnostic Market Dynamics
  • 2.3.1 Companion Diagnostic Industry Trends
  • 2.3.2 Companion Diagnostic Market Drivers
  • 2.3.3 Companion Diagnostic Market Challenges
  • 2.3.4 Companion Diagnostic Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Companion Diagnostic Players by Revenue
  • 3.1.1 Global Top Companion Diagnostic Players by Revenue (2017-2022)
  • 3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2017-2022)
• 3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Companion Diagnostic Revenue
• 3.4 Global Companion Diagnostic Market Concentration Ratio
  • 3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021
• 3.5 Companion Diagnostic Key Players Head office and Area Served
• 3.6 Key Players Companion Diagnostic Product Solution and Service
• 3.7 Date of Enter into Companion Diagnostic Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Breakdown Data by Type

• 4.1 Global Companion Diagnostic Historic Market Size by Type (2017-2022)
• 4.2 Global Companion Diagnostic Forecasted Market Size by Type (2023-2028)

5 Companion Diagnostic Breakdown Data by Application

• 5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022)
• 5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Companion Diagnostic Market Size (2017-2028)
• 6.2 North America Companion Diagnostic Market Size by Type
  • 6.2.1 North America Companion Diagnostic Market Size by Type (2017-2022)
  • 6.2.2 North America Companion Diagnostic Market Size by Type (2023-2028)
  • 6.2.3 North America Companion Diagnostic Market Share by Type (2017-2028)
• 6.3 North America Companion Diagnostic Market Size by Application
  • 6.3.1 North America Companion Diagnostic Market Size by Application (2017-2022)
  • 6.3.2 North America Companion Diagnostic Market Size by Application (2023-2028)
  • 6.3.3 North America Companion Diagnostic Market Share by Application (2017-2028)
• 6.4 North America Companion Diagnostic Market Size by Country
  • 6.4.1 North America Companion Diagnostic Market Size by Country (2017-2022)
  • 6.4.2 North America Companion Diagnostic Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Companion Diagnostic Market Size (2017-2028)
• 7.2 Europe Companion Diagnostic Market Size by Type
  • 7.2.1 Europe Companion Diagnostic Market Size by Type (2017-2022)
  • 7.2.2 Europe Companion Diagnostic Market Size by Type (2023-2028)
  • 7.2.3 Europe Companion Diagnostic Market Share by Type (2017-2028)
• 7.3 Europe Companion Diagnostic Market Size by Application
  • 7.3.1 Europe Companion Diagnostic Market Size by Application (2017-2022)
  • 7.3.2 Europe Companion Diagnostic Market Size by Application (2023-2028)
  • 7.3.3 Europe Companion Diagnostic Market Share by Application (2017-2028)
• 7.4 Europe Companion Diagnostic Market Size by Country
  • 7.4.1 Europe Companion Diagnostic Market Size by Country (2017-2022)
  • 7.4.2 Europe Companion Diagnostic Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Companion Diagnostic Market Size (2017-2028)
• 8.2 Asia-Pacific Companion Diagnostic Market Size by Type
  • 8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Companion Diagnostic Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Companion Diagnostic Market Size by Application
  • 8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Companion Diagnostic Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Companion Diagnostic Market Size by Region
  • 8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Companion Diagnostic Market Size (2017-2028)
• 9.2 Latin America Companion Diagnostic Market Size by Type
  • 9.2.1 Latin America Companion Diagnostic Market Size by Type (2017-2022)
  • 9.2.2 Latin America Companion Diagnostic Market Size by Type (2023-2028)
  • 9.2.3 Latin America Companion Diagnostic Market Share by Type (2017-2028)
• 9.3 Latin America Companion Diagnostic Market Size by Application
  • 9.3.1 Latin America Companion Diagnostic Market Size by Application (2017-2022)
  • 9.3.2 Latin America Companion Diagnostic Market Size by Application (2023-2028)
  • 9.3.3 Latin America Companion Diagnostic Market Share by Application (2017-2028)
• 9.4 Latin America Companion Diagnostic Market Size by Country
  • 9.4.1 Latin America Companion Diagnostic Market Size by Country (2017-2022)
  • 9.4.2 Latin America Companion Diagnostic Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Companion Diagnostic Market Size (2017-2028)
• 10.2 Middle East & Africa Companion Diagnostic Market Size by Type
  • 10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Companion Diagnostic Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Companion Diagnostic Market Size by Application
  • 10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Companion Diagnostic Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Companion Diagnostic Market Size by Country
  • 10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Roche Holdings
  • 11.1.1 Roche Holdings Company Details
  • 11.1.2 Roche Holdings Business Overview
  • 11.1.3 Roche Holdings Companion Diagnostic Introduction
  • 11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2017-2022)
  • 11.1.5 Roche Holdings Recent Developments
• 11.2 Abbott Laboratories
  • 11.2.1 Abbott Laboratories Company Details
  • 11.2.2 Abbott Laboratories Business Overview
  • 11.2.3 Abbott Laboratories Companion Diagnostic Introduction
  • 11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022)
  • 11.2.5 Abbott Laboratories Recent Developments
• 11.3 Thermo Fisher Scientific
  • 11.3.1 Thermo Fisher Scientific Company Details
  • 11.3.2 Thermo Fisher Scientific Business Overview
  • 11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
  • 11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022)
  • 11.3.5 Thermo Fisher Scientific Recent Developments
• 11.4 Agilent Technologies
  • 11.4.1 Agilent Technologies Company Details
  • 11.4.2 Agilent Technologies Business Overview
  • 11.4.3 Agilent Technologies Companion Diagnostic Introduction
  • 11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022)
  • 11.4.5 Agilent Technologies Recent Developments
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Merck Business Overview
  • 11.5.3 Merck Companion Diagnostic Introduction
  • 11.5.4 Merck Revenue in Companion Diagnostic Business (2017-2022)
  • 11.5.5 Merck Recent Developments
• 11.6 Agendia
  • 11.6.1 Agendia Company Details
  • 11.6.2 Agendia Business Overview
  • 11.6.3 Agendia Companion Diagnostic Introduction
  • 11.6.4 Agendia Revenue in Companion Diagnostic Business (2017-2022)
  • 11.6.5 Agendia Recent Developments
• 11.7 Qiagen
  • 11.7.1 Qiagen Company Details
  • 11.7.2 Qiagen Business Overview
  • 11.7.3 Qiagen Companion Diagnostic Introduction
  • 11.7.4 Qiagen Revenue in Companion Diagnostic Business (2017-2022)
  • 11.7.5 Qiagen Recent Developments
• 11.8 Myriad Genetics
  • 11.8.1 Myriad Genetics Company Details
  • 11.8.2 Myriad Genetics Business Overview
  • 11.8.3 Myriad Genetics Companion Diagnostic Introduction
  • 11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022)
  • 11.8.5 Myriad Genetics Recent Developments
• 11.9 Advanced Cell Diagnostics
  • 11.9.1 Advanced Cell Diagnostics Company Details
  • 11.9.2 Advanced Cell Diagnostics Business Overview
  • 11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
  • 11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022)
  • 11.9.5 Advanced Cell Diagnostics Recent Developments
• 11.10 Danaher
  • 11.10.1 Danaher Company Details
  • 11.10.2 Danaher Business Overview
  • 11.10.3 Danaher Companion Diagnostic Introduction
  • 11.10.4 Danaher Revenue in Companion Diagnostic Business (2017-2022)
  • 11.10.5 Danaher Recent Developments
• 11.11 Illumina, Inc
  • 11.11.1 Illumina, Inc Company Details
  • 11.11.2 Illumina, Inc Business Overview
  • 11.11.3 Illumina, Inc Companion Diagnostic Introduction
  • 11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022)
  • 11.11.5 Illumina, Inc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Immunohistochemistry
• Table 3. Key Players of Molecular Diagnosis
• Table 4. Global Companion Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Companion Diagnostic Market Share by Region (2017-2022)
• Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Companion Diagnostic Market Share by Region (2023-2028)
• Table 10. Companion Diagnostic Market Trends
• Table 11. Companion Diagnostic Market Drivers
• Table 12. Companion Diagnostic Market Challenges
• Table 13. Companion Diagnostic Market Restraints
• Table 14. Global Companion Diagnostic Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Companion Diagnostic Revenue Share by Players (2017-2022)
• Table 16. Global Top Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
• Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Companion Diagnostic Product Solution and Service
• Table 21. Date of Enter into Companion Diagnostic Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 24. Global Companion Diagnostic Revenue Market Share by Type (2017-2022)
• Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 26. Global Companion Diagnostic Revenue Market Share by Type (2023-2028)
• Table 27. Global Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Companion Diagnostic Revenue Share by Application (2017-2022)
• Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Companion Diagnostic Revenue Share by Application (2023-2028)
• Table 31. North America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 32. North America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 33. North America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 38. Europe Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 39. Europe Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Companion Diagnostic Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 61. Roche Holdings Company Details
• Table 62. Roche Holdings Business Overview
• Table 63. Roche Holdings Companion Diagnostic Product
• Table 64. Roche Holdings Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 65. Roche Holdings Recent Developments
• Table 66. Abbott Laboratories Company Details
• Table 67. Abbott Laboratories Business Overview
• Table 68. Abbott Laboratories Companion Diagnostic Product
• Table 69. Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 70. Abbott Laboratories Recent Developments
• Table 71. Thermo Fisher Scientific Company Details
• Table 72. Thermo Fisher Scientific Business Overview
• Table 73. Thermo Fisher Scientific Companion Diagnostic Product
• Table 74. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 75. Thermo Fisher Scientific Recent Developments
• Table 76. Agilent Technologies Company Details
• Table 77. Agilent Technologies Business Overview
• Table 78. Agilent Technologies Companion Diagnostic Product
• Table 79. Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 80. Agilent Technologies Recent Developments
• Table 81. Merck Company Details
• Table 82. Merck Business Overview
• Table 83. Merck Companion Diagnostic Product
• Table 84. Merck Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 85. Merck Recent Developments
• Table 86. Agendia Company Details
• Table 87. Agendia Business Overview
• Table 88. Agendia Companion Diagnostic Product
• Table 89. Agendia Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 90. Agendia Recent Developments
• Table 91. Qiagen Company Details
• Table 92. Qiagen Business Overview
• Table 93. Qiagen Companion Diagnostic Product
• Table 94. Qiagen Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 95. Qiagen Recent Developments
• Table 96. Myriad Genetics Company Details
• Table 97. Myriad Genetics Business Overview
• Table 98. Myriad Genetics Companion Diagnostic Product
• Table 99. Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 100. Myriad Genetics Recent Developments
• Table 101. Advanced Cell Diagnostics Company Details
• Table 102. Advanced Cell Diagnostics Business Overview
• Table 103. Advanced Cell Diagnostics Companion Diagnostic Product
• Table 104. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 105. Advanced Cell Diagnostics Recent Developments
• Table 106. Danaher Company Details
• Table 107. Danaher Business Overview
• Table 108. Danaher Companion Diagnostic Product
• Table 109. Danaher Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 110. Danaher Recent Developments
• Table 111. Illumina, Inc Company Details
• Table 112. Illumina, Inc Business Overview
• Table 113. Illumina, Inc Companion Diagnostic Product
• Table 114. Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
• Table 115. Illumina, Inc Recent Developments
• Table 116. Research Programs/Design for This Report
• Table 117. Key Data Information from Secondary Sources
• Table 118. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Companion Diagnostic Market Share by Type: 2021 VS 2028
• Figure 2. Immunohistochemistry Features
• Figure 3. Molecular Diagnosis Features
• Figure 4. Global Companion Diagnostic Market Share by Application: 2021 VS 2028
• Figure 5. Oncology Case Studies
• Figure 6. Cardiovascular Case Studies
• Figure 7. Central Nervous System Case Studies
• Figure 8. Virology Case Studies
• Figure 9. Others Case Studies
• Figure 10. Companion Diagnostic Report Years Considered
• Figure 11. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 12. Global Companion Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Companion Diagnostic Market Share by Region: 2021 VS 2028
• Figure 14. Global Companion Diagnostic Market Share by Players in 2021
• Figure 15. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
• Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2021
• Figure 17. North America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 18. North America Companion Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 19. North America Companion Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 20. North America Companion Diagnostic Market Size Share by Country (2017-2028)
• Figure 21. United States Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Canada Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 23. Europe Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 24. Europe Companion Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 25. Europe Companion Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 26. Europe Companion Diagnostic Market Size Share by Country (2017-2028)
• Figure 27. Germany Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. France Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. U.K. Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Italy Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Russia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Nordic Countries Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Asia-Pacific Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 34. Asia Pacific Companion Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 35. Asia Pacific Companion Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 36. Asia Pacific Companion Diagnostic Market Size Share by Region (2017-2028)
• Figure 37. China Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. Japan Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. South Korea Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Southeast Asia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. India Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. Australia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 43. Latin America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 44. Latin America Companion Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 45. Latin America Companion Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 46. Latin America Companion Diagnostic Market Size Share by Country (2017-2028)
• Figure 47. Mexico Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Brazil Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 49. Middle East & Africa Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 50. Middle East and Africa Companion Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 51. Middle East and Africa Companion Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 52. Middle East and Africa Companion Diagnostic Market Size Share by Country (2017-2028)
• Figure 53. Turkey Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. UAE Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 57. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 59. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 60. Merck Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 61. Agendia Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 62. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 63. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 64. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 65. Danaher Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 66. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
• Figure 67. Bottom-up and Top-down Approaches for This Report
• Figure 68. Data Triangulation
• Figure 69. Key Executives Interviewed